Elite in Long Haul COVID

Christopher E. Brightling

University Road, 
Leicester, ENG, GB 
Elite in Long Haul COVID
University Road, 
Leicester, ENG, GB 
OverviewLocationsClinical Research

Overview

Christopher Brightling practices in Leicester, United Kingdom. Mr. Brightling is rated as an Elite expert by MediFind in the treatment of Long Haul COVID. His top areas of expertise are Asthma, Chronic Obstructive Pulmonary Disease (COPD), Long Haul COVID, and COVID-19.

His clinical research consists of co-authoring 158 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 18 articles in the study of Long Haul COVID.

Gender
Male

Locations

University Road, Leicester, ENG, United Kingdom

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Randomised Controlled Trial of Mepolizumab Initiated Following Admission to Hospital for a Severe Exacerbation of Eosinophilic COPD
A Randomised Controlled Trial of Mepolizumab Initiated Following Admission to Hospital for a Severe Exacerbation of Eosinophilic COPD
Enrollment Status: Completed
Publish Date: July 01, 2024
Intervention Type: Drug
Study Drug: Mepolizumab
Study Phase: Phase 2/Phase 3
A Randomised Placebo-controlled Trial of Anti-ST2 in COPD (COPD-ST2OP)
A Randomised Placebo-controlled Trial of Anti-ST2 in COPD (COPD-ST2OP)
Enrollment Status: Completed
Publish Date: June 21, 2022
Intervention Type: Drug
Study Phase: Phase 2
View 1 Less Clinical Trial

158 Total Publications

HLA-B*15:01-positive severe COVID-19 patients lack CD8+ T cell pools with highly expanded public clonotypes.
HLA-B*15:01-positive severe COVID-19 patients lack CD8+ T cell pools with highly expanded public clonotypes.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: September 02, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Brightling's expertise for a condition
ConditionClose
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile